| Name | 5-(2-Methoxyphenoxy)-[2,2-Bipyrimidine]-4,6(1H,5H)-Dione |
|---|---|
| Synonyms |
(RS)-5-(2-methoxy-phenoxy)-1H-bipyrimidine-4,6-dione
Bosentan Impurity 13 Bosenta dione 5-(2-methoxyphenoxy)-[2,2' 5-(2-methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1h,5h)-dione 5-(2-METHOXYPHENOXY)-2-(PYRIMIDIN-2-YL)PYRIMIDINE-4,6(1H,5H)-DIONE,PURITY: MIN(HPLC) 2,2'-Bipyrimidine]-4,6(1H,5H)-dione, 5-(2-methoxyphenoxy) 5-(2-Methoxyphenxoy)-[2,2'-bipyrimidine]-4 5-(2-Methoxyphenxoy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione 5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidine-4,6(1H,5H)-dione Bosentan interMediate 5- (2-Methoxyphenoxy) - [2,2 '- pyrimidine] -4,6 (1H, 5H) - dione 5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione 5-(2-Methoxyphenoxy)-[2,2'-BipyriMidine]-4,6(1H,5H) 5-(2-Methoxyphenoxy)-2-(pyriMidin-2-yl)-1,4,5,6-tetrahydropyriMidine-4,6-dione 5- (2-Methoxyphenoxy) - [2,2 '- Dipyrimidine] -4,6 (1H, 5H) - dione 5-(O-methoxyphenoxy)-2-pymidin-2-yl)-4,6-(1H,5H)-pymidine dione 5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione CAS NO.150-4 CAS NO.150-4 5-(2-Methoxyphenoxy)-2,2'-bipyrimidine-4,6(1H,5H)-dione |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Molecular Formula | C15H12N4O4 |
| Molecular Weight | 312.280 |
| Exact Mass | 312.085846 |
| PSA | 102.77000 |
| LogP | -0.24 |
| Index of Refraction | 1.676 |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933599090 |
|
~%
150728-12-4 |
| Literature: US2012/136015 A1, ; Page/Page column 6-7 ; |
|
~25%
150728-12-4 |
| Literature: AUSPEX PHARMACEUTICALS, INC. Patent: US2008/242687 A1, 2008 ; Location in patent: Page/Page column 32; 34 ; US 20080242687 A1 |
| Precursor 4 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |